Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Daiichi Sankyo

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Daiichi Sankyo's 2012 sales performance.

Daiichi Sankyo

Genentech taps into Sosei Heptares GPCR expertise with $1bn alliance

Genentech taps into Sosei Heptares GPCR expertise with $1bn alliance

Sosei Heptares has developed considerable expertise in GPCRs that has allowed it to attract a string of partners, with Genentech joining Pfizer, AstraZeneca, Allergan, Novartis, and Daiichi-Sankyo, amongst others.

Research charity LifeArc cashes $1.2bn royalty from Keytruda

Research charity LifeArc cashes $1.2bn royalty from Keytruda In March it formed a cancer immunotherapy alliance with CRUK and Ono Pharma, in April it licensed an ion channel drug discovery programme to Daiichi Sankyo, and in early May it

One hit, one miss as FDA panel votes on Daiichi’s cancer drugs

One hit, one miss as FDA panel votes on Daiichi’s cancer drugs separately gave Daiichi Sankyo some succour by backing pexidartinib for a rare condition called tenosynovial giant cell tumour (TGCT). ... tissues. Daiichi Sankyo acquired the drug when it bought Taiwanese firm Plexxikon for almost $1bn in 2011.

Pfizer’s alliance with Sosei Heptares bears first fruit

Pfizer’s alliance with Sosei Heptares bears first fruit Pfizer is just one of Sosei Heptares’ big pharma partners, and the company has also attracted sizeable collaborations with AstraZeneca, Allergan, Novartis, and Daiichi-Sankyo.

AZ’s bet on Daiichi’s rival to Kadcyla pays off

AZ’s bet on Daiichi’s rival to Kadcyla pays off Pivotal phase 2 data backs investment. AstraZeneca has the positive pivotal trial it needed to justify its big investment in Daiichi’s HER2-targeting antibody-drug conjugate DS-8201, a rival ... There are no anti-HER2 therapies currently approved for

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics